Humana Inc HUM Announces Strategic Pharmacy Partnership With Mark Cuban Cost Plus Drug Company to Drive Prescription Affordability and TopLine Growth Is Insight Enterprises NSIT stock fairly valued by the market Insight Enterprises beats EPS estimates by 22 pct FHNH First reports no available quarterly earnings or revenue data for its Series H preferred shares